Dr. Epstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
621 Ridgely Ave
Ste 201
Annapolis, MD 21401Phone+1 410-224-4887Fax+1 410-224-1428
Education & Training
- MedStar Health/Georgetown University HospitalFellowship, Gastroenterology, 1984 - 1986
- George Washington UniversityResidency, Internal Medicine, 1981 - 1984
- Rutgers New Jersey Medical SchoolClass of 1981
Certifications & Licensure
- MD State Medical License 1986 - 2026
- FL State Medical License 2014 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (AGAF) American Gastroenterological Association, 2007
- Fellow (FACG) American College of Gastroenterology
Clinical Trials
- Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease Start of enrollment: 2013 Sep 01
Publications & Presentations
PubMed
- 10 citationsNovel endoscopic delivery modality of infrared coagulation therapy for internal hemorrhoidsElisabeth C. McLemore, Rudra Rai, Junaid Siddiqui, Patrick Basu, Mousab Tabbaa
Surgical Endoscopy. 2012-05-31 - 89 citationsA Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome SymptomsBrooks D. Cash, Michael S. Epstein, Syed M. Shah
Digestive Diseases and Sciences. 2016-02-01 - 76 citationsA dual-action, low-volume bowel cleanser administered the day before colonoscopy: results from the SEE CLEAR II study.Philip O. Katz, Douglas K. Rex, Michael S. Epstein, Nav Grandhi, Stephen Vanner
The American Journal of Gastroenterology. 2013-03-01
Press Mentions
- 36-Month Post-Marketing Surveillance Report for FDgard®, Now Available for Review at the American College of Gastroenterology (ACG) E-poster WebsiteOctober 26th, 2020
- For the Sixth Year in A Row, in A Survey of Gastroenterologists' Preferences for IBS Products, IBgard® Widens Its Already Preeminent "#1 Recommended"[1] StatusAugust 10th, 2020
- Unprecedented 3-Year Safety Data Unveiled at Digestive Disease Week (DDW) Indicates No Pattern of Heartburn with IBgard®, an Advanced Technology Peppermint Oil, Contrary to Heartburn Issues with Older TechnologiesMay 5th, 2020
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: